Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group Study.
暂无分享，去创建一个
R. Sylvester | H. Mouridsen | A. V. van Oosterom | W. Steward | G. Blackledge | J. Rouessé | D. Thomas | J. Buesa | A. Oosterom | J. Rouesse